Yu Z, Du J, Zhao Y, Gao Y, et al. A novel kinase inhibitor, LZT-106, downregulates Mcl-1 and sensitizes colorectal
cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3beta signaling. Cancer Lett 2020 Oct 28. pii: S0304-3835(20)30499.
PMID: 33129955